{"id":441638,"date":"2021-02-23T07:08:13","date_gmt":"2021-02-23T12:08:13","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441638"},"modified":"2021-02-23T07:08:13","modified_gmt":"2021-02-23T12:08:13","slug":"clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/","title":{"rendered":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ALPHARETTA, Ga., Feb.  23, 2021  (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the Company will participate in two upcoming investor conferences in March 2021:<\/p>\n<p align=\"justify\">Cowen 41st Annual Health Care Conference<br \/>Blazing New Paths in Clinical Development and Structure Panel<br \/>Tuesday, March 2, 2021 at 2:10 pm ET<\/p>\n<p align=\"justify\">33rd Annual ROTH Conference <br \/>Ophthalmology Panel<br \/>Tuesday, March 16, 2021 at 9:00 am ET<\/p>\n<p align=\"justify\">The panels will be available for attendees on the conference websites. Management will be participating in live, virtual one-on-one meetings with investors who are registered to attend the conferences.<\/p>\n<p align=\"justify\">\n        <strong>About Clearside Biomedical<\/strong>\n      <\/p>\n<p align=\"justify\">Clearside Biomedical, Inc. is a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases. Clearside\u2019s proprietary SCS Microinjector<sup>\u00ae<\/sup> targets the suprachoroidal space (SCS<sup>\u00ae<\/sup>) and offers unique access to the macula, retina and choroid where sight-threatening disease often occurs. The Company\u2019s SCS injection platform is an inherently flexible, in-office, non-surgical procedure, intended to provide targeted delivery to the site of disease and to work with both established and new formulations of medications, as well as future therapeutic innovations. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FiuX2_OlXs1AVaenJhRCTzRjcCIvOaeVQkAphSjILAoorLKSckJl_1sPGV-JKjf3vMEA2yfCT1_p8c43AKR6AaKjoOWTfOzoQzfYxknQ_MI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.clearsidebio.com<\/a>.<\/p>\n<p>\n        <strong>Investor and Media Contacts:<\/strong><\/p>\n<p>Jenny Kobin <br \/>Remy Bernarda <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Nb-xV5YN0WM2zCZcHAyGbx4z2X23ceoYKmviAeASFgBEqjYSGQ_m1VV3Chw6GwZmCLxMBifhAtllnJ8JhqU6ZJE5REe9ug46lH5UwutHWNM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir@clearsidebio.com<\/a><br \/>(678) 430-8206<\/p>\n<p>Source: Clearside Biomedical, Inc.<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/e6c52ee5-1c61-4b54-b44d-be5024892746\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALPHARETTA, Ga., Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the Company will participate in two upcoming investor conferences in March 2021: Cowen 41st Annual Health Care ConferenceBlazing New Paths in Clinical Development and Structure PanelTuesday, March 2, 2021 at 2:10 pm ET 33rd Annual ROTH Conference Ophthalmology PanelTuesday, March 16, 2021 at 9:00 am ET The panels will be available for attendees on the conference websites. Management will be participating in live, virtual one-on-one meetings with investors who are registered to attend the conferences. About Clearside Biomedical Clearside Biomedical, Inc. is a &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441638","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALPHARETTA, Ga., Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the Company will participate in two upcoming investor conferences in March 2021: Cowen 41st Annual Health Care ConferenceBlazing New Paths in Clinical Development and Structure PanelTuesday, March 2, 2021 at 2:10 pm ET 33rd Annual ROTH Conference Ophthalmology PanelTuesday, March 16, 2021 at 9:00 am ET The panels will be available for attendees on the conference websites. Management will be participating in live, virtual one-on-one meetings with investors who are registered to attend the conferences. About Clearside Biomedical Clearside Biomedical, Inc. is a &hellip; Continue reading &quot;Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T12:08:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021\",\"datePublished\":\"2021-02-23T12:08:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/\"},\"wordCount\":235,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/\",\"name\":\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=\",\"datePublished\":\"2021-02-23T12:08:13+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/","og_locale":"en_US","og_type":"article","og_title":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 - Market Newsdesk","og_description":"ALPHARETTA, Ga., Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced today that the Company will participate in two upcoming investor conferences in March 2021: Cowen 41st Annual Health Care ConferenceBlazing New Paths in Clinical Development and Structure PanelTuesday, March 2, 2021 at 2:10 pm ET 33rd Annual ROTH Conference Ophthalmology PanelTuesday, March 16, 2021 at 9:00 am ET The panels will be available for attendees on the conference websites. Management will be participating in live, virtual one-on-one meetings with investors who are registered to attend the conferences. About Clearside Biomedical Clearside Biomedical, Inc. is a &hellip; Continue reading \"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T12:08:13+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021","datePublished":"2021-02-23T12:08:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/"},"wordCount":235,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/","name":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=","datePublished":"2021-02-23T12:08:13+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzYxMCMzOTg5NzMxIzIwMTExNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-participate-in-two-upcoming-investor-conferences-in-march-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441638"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441638\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}